SEARCH

SEARCH BY CITATION

REFERENCES

  • Albert PR, Benkelfat C. 2013. The neurobiology of depression—revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies. Philos Trans R Soc Lond B Biol Sci 368: 20120535.
  • Albert PR, Benkelfat C, Descarries L. 2012. The Neurobiology of depression—revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms. Philos Trans R Soc London [Biol] 367: 23782381.
  • Barkai AI, Dunner DL, Gross HA, Mayo P, Fieve RR. 1978. Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol Psychiatry 13: 6572.
  • Benjamin J, Agam G, Levine J, Bersudsky Y, Kofman O, Belmaker RH. 1995a. Inositol treatment in psychiatry. Psychopharmacol Bull 31: 167175.
  • Benjamin J, Levine J, Fux M, Aviv A, Levy D, Belmaker RH. 1995b. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 152: 10841086.
  • Boulenger JP, Fournier M, Rosales D, Lavallee YJ. 1997. Mixed anxiety and depression: from theory to practice. J Clin Psychiatry 58(Suppl 8): 2734.
  • Camfield DA, Sarris J, Berk M. 2011. Nutraceuticals in the treatment of obsessive–compulsive disorder (OCD): a review of mechanistic and clinical evidence. Prog Neuropsychopharmacol Biol Psychiatry 35: 887895.
  • Chengappa KN, Levine J, Gershon S, Mallinger AG, Hardan A, Vagnucci A, et al. 2000. Inositol as an add-on treatment for bipolar depression. Bipolar disorders 2: 4755.
  • Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS. 2005. Decreased prefrontal myo-inositol in major depressive disorder. Biol Psychiatry 57: 15261534.
  • DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Controlled Clin Trials 7: 177188.
  • Eden Evins A, Demopulos C, Yovel I, Culhane M, Ogutha J, Grandin LD, et al. 2006. Inositol augmentation of lithium or valproate for bipolar depression. Bipolar disorders 8: 168174.
  • Epperson CN, Steiner M, Hartlage SA, Eriksson E, Schmidt PJ, Jones I, et al. 2012. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry 169: 465475.
  • Fux M, Levine J, Aviv A, Belmaker RH. 1996. Inositol treatment of obsessive–compulsive disorder. Am J Psychiatry 153: 12191221.
  • Fux M, Benjamin J, Belmaker RH. 1999. Inositol versus placebo augmentation of serotonin reuptake inhibitors in the treatment of obsessive–compulsive disorder: a double-blind cross-over study. The international journal of neuropsychopharmacology//official scientific journal of the Collegium Internationale Neuropsychopharmacologicum 2: 193195.
  • Gianfranco C, Vittorio U, Silvia B, Francesco D. 2011. Myo-inositol in the treatment of premenstrual dysphoric disorder. Hum Psychopharm 26: 526530.
  • Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. 1989. The Yale–Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46: 10061011.
  • Guy W, Bonato RR. 1970. Manual for the ECDEU Assessment Battery, 2nd ed. Chevy Chase, Md, National Institute of Mental Health.
  • Hamilton M. 1959. The assessment of anxiety states by rating. Br J Med Psychol 32: 5055.
    Direct Link:
  • Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 5662.
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. Bmj 327: 557560.
  • Kaplan Z, Amir M, Swartz M, Levine J. 1996. Inositol treatment of post-traumatic stress disorder. Anxiety 2: 5152.
  • Levine J, Barak Y, Gonzalves M, Szor H, Elizur A, Kofman O, et al. 1995. Double-blind, controlled trial of inositol treatment of depression. Am J Psychiatry 152: 792794.
  • Levine J, Mishori A, Susnosky M, Martin M, Belmaker RH. 1999. Combination of inositol and serotonin reuptake inhibitors in the treatment of depression. Biol Psychiatry 45: 270273.
  • Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Bmj 339: b2535.
  • Nemets B, Mishory A, Levine J, Belmaker RH. 1999. Inositol addition does not improve depression in SSRI treatment failures. J Neural Transm 106: 795798.
  • Nemets B, Talesnick B, Belmaker RH, Levine J. 2002. Myo-inositol has no beneficial effect on premenstrual dysphoric disorder. The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry 3: 147149.
  • Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE. 1997. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry 154: 11481150.
  • Taylor MJ, Wilder H, Bhagwagar Z, Geddes J. 2004. Inositol for depressive disorders. Cochrane database of systematic reviews.:CD004049.